Vascular Endothelium and Vector Borne Pathogen Interactions Moez Berrich*,1, Henri-Jean Boulouis1, Martine Monteil1, Claudine Kieda2 and Nadia Haddad*,1

Total Page:16

File Type:pdf, Size:1020Kb

Vascular Endothelium and Vector Borne Pathogen Interactions Moez Berrich*,1, Henri-Jean Boulouis1, Martine Monteil1, Claudine Kieda2 and Nadia Haddad*,1 Current Immunology Reviews, 2012, 8, 227-247 227 Vascular Endothelium and Vector Borne Pathogen Interactions Moez Berrich*,1, Henri-Jean Boulouis1, Martine Monteil1, Claudine Kieda2 and Nadia Haddad*,1 1UPE, Ecole Nationale Vétérinaire d'Alfort, UMR BIPAR, ENVA, ANSES, UPEC, USC INRA, 23, rue du Gl de Gaulle - 94703 Maisons-Alfort, France 2Centre de Biophysique Moléculaire, Centre National de la Recherche Scientifique, Unité Propre de Recherche 4301, 45045 Orléans, France Abstract: The endothelium is the thin layer of cells that lines the lumen of blood and lymphatic vessels. Endothelial cells (ECs) from different locations have distinct and characteristic expression patterns that persist during in vitro culture. Although gene expression patterns in cultured cells clearly reveal the molecular heterogeneity of these ECs, their corelation with their in vivo counterparts remains to be defined. Situated at the interface between blood and tissues, the endothelium plays a central role for critical functions and represents a physical barrier for both blood-borne pathogens and immune cells, which must cross this barrier for trafficking between the bloodstream and tissues. Endothelial cells are target cells for several infectious agents, including Anaplasma, Bartonella, Orientia and Rickettsia. The lack of appropriate spontaneous or experimentally-induced animal models is a serious limitation for the study of pathogen-ECs interactions and is the major justification for the use of ECs cultures. Bartonella adherence to ECs is mediated by type-IV like pili and some outer membrane proteins. Some differences exist among Bartonella species adherence mechanisms. ECs are invaded either by an endocytic uptake or by engulfment of Bartonella. The activation of ECs by chronic inflammation and direct or indirect action of some Bartonella species leads to proliferation, angiogenesis and vasoproliferative tumor growth. Interactions between Anaplasma, Orientia, Rickettsia and ECs are less documented than Bartonella but differ significantly from the mechanisms described for Bartonella. At the least, they do not induce vasoproliferation. This review summarizes our understanding of the diversity of ECs, the vector borne bacterium-ECs interactions and the mechanisms of bacterial virulence and persistence. Keywords: Anaplasma, angiogenesis, apoptosis, Bartonella, endothelial cells, heterogeneity, interactions, macrophages, organ specificity, Orientia, Rickettsia, tumor, vascular endothelium, vector borne bacteria, VEGF. INTRODUCTION Accordingly, in vitro evidence of ECs infection is not sufficient, but can contribute to clarify some pathological The endothelium is a single layer of endothelial cells mechanisms. The lack of appropriate spontaneous or (ECs) that lines the lumen of blood and lymphatic vessels. experimentally-induced animal models is a serious limitation ECs are very heterogeneous and constitute diverse for the study of pathogen-ECs interactions and is the major populations with great differences [1] according to the type justification for the use of ECs cultures. of vessel and the organ they belong to and the biological state [2]. The endothelium is not a passive barrier and plays During infection within hosts the ECs-bacteria important roles in the development and remodeling of interactions result into a broad range of clinical vasculature, maintenance of vascular tone, blood fluidity, manifestations. The list of bacteria that have been found able coagulation, nutrient exchange, homeostasis, angiogenesis, to subvert certain cellular functions, resulting in cell organ development and inflammation [3]. Moreover, ECs invasion, proinflamatory activation and modulation of represent a physical barrier to both blood-borne pathogens apoptosis is limited to some -Proteobacteria (Fig. 1), the and immune cells which must cross this barrier for majority of which belong to the order of Rickettsiales. This trafficking between tissues and the bloodstream. order is composed by two families, the Rickettsiaceae (genus Rickettsia and Orientia) and the Anaplasmataceae (that ECs are target cells for several infectious agents includes the genus Anaplasma, Ehrlichia, Neorickettsia and including some pathogenic bacteria. Valbuena and Walker Wolbachia) [5]. Anaplasma-infected ECs lead to unique [4] have proposed the three following criteria as necessary pathogen-specific host cell functional alterations that are for considering the relationships between pathogenic bacteria likely to be important for pathogen survival, pathogenesis and ECs as significant in the pathological process: Bacteria and human disease induction [6]. Orientia causes vasculitis intracellular location in the ECs of natural hosts; Bacteria in humans by replicating inside macrophages and ECs [7]. must be able to multiply in ECs and the endothelium must be Rickettsiae cause life threatening spotted fevers and typhus a consistent target of the infection during the disease. fevers via bacterial transmission by arthropod inoculation into skin, followed by hematogenous spread and disseminated ECs infection [4]. Some members of another *Address correspondence to this author at the Ecole Nationale Vétérinaire d'Alfort - UMR BIPAR, ENVA, ANSES, UPEC, USC INRA, LERPAZ, 7 family, the Bartonellaceae, not belonging to the Rickettsiales avenue du Général de Gaulle, 94704 Maisons-Alfort, France; order, but closer to the genera Agrobacterium, Brucella, and Tel: 00 33 1 43 96 73 15; Fax: 00 33 1 43 96 71 31; Rhizobium can trigger massive proliferation of ECs, leading E-mails: [email protected]; [email protected] to vascular tumor formation [8-9]. 1875-631X/12 $58.00+.00 © 2012 Bentham Science Publishers 228 Current Immunology Reviews, 2012, Vol. 8, No. 3 Berrich et al. Fig. (1). Different degrees of consequences of intra-cellular infection by bacteria that are able to replicate in ECs. As shown in the figure, the bacteria that are able to induce an anti-apoptotic effect (2) are a fortiori able to induce a persistant bacteremia (1), and the bacteria that are able to induce an angiogenic effect (3) are also able to induce an anti-apoptotic effect. *In various blood cells according to the genus. Understanding the mechanisms that contribute to highly complex topology of the endothelium. The pathogens/endothelium interactions is essential to approach understanding of this complexity improved thanks to the in the processes by which infectious agents penetrate the vitro models of endothelium. Immunohistochemical analyses endothelial barrier and to control the clinical outcome of showed that antigen expression and glycosylation patterns such infectious diseases. are different according to the different organs and tissues where the ECs are originating from [14-20]. This review is dedicated to the study of these interactions and will not consider the sepsis mediated endothelial injury. Bizouarne et al. [21] have demonstrated the fine difference between ECs from the high endothelial ORGAN SPECIFICITY AND HETEROGENEITY OF postcapillary venules (HEV) in peripheral lymph nodes ENDOTHELIAL CELLS (PLN) compared to the cells from the post capillary veinules of the Peyer’s Patches (PP) at the molecular and functional ECs are morphologically and functionally heterogeneous levels. These cells from the HEV in their respective with major differences between those from the macro- versus secondary lymphoid organs, are responsible for the selection micro-circulation as documented for a variety of tissues [10]. of distinct lymphocyte populations. As such, they are They differ morphologically, in size, shape, thickness, regulating the homing process of lymphocytes during the number of microvilli, and position of the nucleus [11] and immune response. Bizouarne et al. [22] and Denis et al. [23] functionally by differences in the released substances and in demonstrated that human ECs from PLN and PP are their interactions with leukocytes and pathogens [12]. responsible for distinct gene expression of adhesion molecules and distinct expression of addressins as well as This heterogeneous population of vascular endothelium distinct endogenous lectin expression and activity. The cells specializes in response to genetic programs and “organo specificity” of the endothelium was proven by environmental factors, which contribute to their ability to Kieda et al. [2] who have established endothelial in vitro play distinct roles in different vessels, tissues, organs, and models representative of the various lymphoid and response to stresses and infection [11]. The endothelium phenotypic diversity reflects the biological needs of the peripheral tissues (Table 1). Moreover, Lamerant and Kieda [24] have used the differential gene expression display to underlying tissue as illustrated by the five distinct ECs types identify endothelial genes that are distinctively expressed and phenotypes of the heart (endocardial, coronary arterial, between those ECs from distinct tissue origin. venous, capillary, and lymphatic). Coronary ECs establish a typical network throughout the myocardium, whereas Several studies support this concept. For example, the endocardial ECs form a large epithelial sheet with no plasma glycoprotein known as von Willebrand factor, is sprouting into the myocardium [13]. prominent in veins, less prominent in arteries, and largely absent from sinusoidal ECs; the endothelial protein C While the cultured ECs became a focal point for research receptor is predominantly expressed by large vessel ECs in vascular biology, increasing evidence
Recommended publications
  • Genetic Diversity of Bartonella Species in Small Mammals in the Qaidam
    www.nature.com/scientificreports OPEN Genetic diversity of Bartonella species in small mammals in the Qaidam Basin, western China Huaxiang Rao1, Shoujiang Li3, Liang Lu4, Rong Wang3, Xiuping Song4, Kai Sun5, Yan Shi3, Dongmei Li4* & Juan Yu2* Investigation of the prevalence and diversity of Bartonella infections in small mammals in the Qaidam Basin, western China, could provide a scientifc basis for the control and prevention of Bartonella infections in humans. Accordingly, in this study, small mammals were captured using snap traps in Wulan County and Ge’ermu City, Qaidam Basin, China. Spleen and brain tissues were collected and cultured to isolate Bartonella strains. The suspected positive colonies were detected with polymerase chain reaction amplifcation and sequencing of gltA, ftsZ, RNA polymerase beta subunit (rpoB) and ribC genes. Among 101 small mammals, 39 were positive for Bartonella, with the infection rate of 38.61%. The infection rate in diferent tissues (spleens and brains) (χ2 = 0.112, P = 0.738) and gender (χ2 = 1.927, P = 0.165) of small mammals did not have statistical diference, but that in diferent habitats had statistical diference (χ2 = 10.361, P = 0.016). Through genetic evolution analysis, 40 Bartonella strains were identifed (two diferent Bartonella species were detected in one small mammal), including B. grahamii (30), B. jaculi (3), B. krasnovii (3) and Candidatus B. gerbillinarum (4), which showed rodent-specifc characteristics. B. grahamii was the dominant epidemic strain (accounted for 75.0%). Furthermore, phylogenetic analysis showed that B. grahamii in the Qaidam Basin, might be close to the strains isolated from Japan and China.
    [Show full text]
  • Detection and Partial Molecular Characterization of Rickettsia and Bartonella from Southern African Bat Species
    Detection and partial molecular characterization of Rickettsia and Bartonella from southern African bat species by Tjale Mabotse Augustine (29685690) Submitted in partial fulfillment of the requirements for the degree MAGISTER SCIENTIAE (MICROBIOLOGY) in the Department of Microbiology and Plant Pathology Faculty of Natural and Agricultural Sciences University of Pretoria Pretoria, South Africa Supervisor: Dr Wanda Markotter Co-supervisors: Prof Louis H. Nel Dr Jacqueline Weyer May, 2012 I declare that the thesis, which I hereby submit for the degree MSc (Microbiology) at the University of Pretoria, South Africa, is my own work and has not been submitted by me for a degree at another university ________________________________ Tjale Mabotse Augustine i Acknowledgements I would like send my sincere gratitude to the following people: Dr Wanda Markotter (University of Pretoria), Dr Jacqueline Weyer (National Institute for Communicable Diseases-National Health Laboratory Service) and Prof Louis H Nel (University of Pretoria) for their supervision and guidance during the project. Dr Jacqueline Weyer (Centre for Zoonotic and Emerging diseases (Previously Special Pathogens Unit), National Institute for Communicable Diseases (National Heath Laboratory Service), for providing the positive control DNA for Rickettsia and Dr Jenny Rossouw (Special Bacterial Pathogens Reference Unit, National Institute for Communicable Diseases-National Health Laboratory Service), for providing the positive control DNA for Bartonella. Dr Teresa Kearney (Ditsong Museum of Natural Science), Gauteng and Northern Region Bat Interest Group, Kwa-Zulu Natal Bat Interest Group, Prof Ara Monadjem (University of Swaziland), Werner Marias (University of Johannesburg), Dr Francois du Rand (University of Johannesburg) and Prof David Jacobs (University of Cape Town) for collection of blood samples.
    [Show full text]
  • Human Case of Bartonella Alsatica Lymphadenitis
    LETTERS (6). The sequence is distinct from a DOI: 10.3201/eid1412.080944 Human Case of small number of sequences derived from rabies viruses in Vietnam, which References Bartonella alsatica suggests that China is a stronger can- Lymphadenitis 1. Smith JS, Fishbein DB, Rupprecht CE, didate for the source of the virus than Clark K. Unexplained rabies in three To the Editor: Lymph node en- her native country. immigrants in the United States: a vi- Although the case history could rologic investigation. N Engl J Med. largement is a common medical prob- not provide evidence for interaction 1991;324:205–11. lem that is usually caused by bacterial, 2. Grattan-Smith PJ, O’Regan WJ, Ellis PS, with a dog while her family was in viral, fungal, or protozoal agents (1). O’Flaherty SJ, McIntyre PB, Barnes CJ. A Malignancies or lymphoproliferative Hong Kong Special Administrative second Australian case, with a long incuba- Region, rabies was endemic within tion period. Med J Aust. 1992;156:651–4. diseases are often found, especially in the colony at the time that the pa- 3. McColl KA, Gould AR, Selleck PW, elderly patients (1). Bartonella hense- Hooper PT, Westbury HA, Smith JS. tient’s family was resident. From 1980 lae, the main causative agent of cat- Polymerase chain reaction and other labo- scratch disease (CSD), appears to be through 1984, 5 human cases were re- ratory techniques in the diagnosis of long corded (9). Only 2 case-patients had incubation rabies in Australia. Aust Vet the most common organism respon- clear evidence of a dog bite; histories J.
    [Show full text]
  • Endocarditis Due to Bartonella Quintana, the Etiological Agent of Trench Fever
    PRACTICE | CASES CPD VULNERABLE POPULATIONS Endocarditis due to Bartonella quintana, the etiological agent of trench fever Carl Boodman MD, Terence Wuerz MD MSc (Epi), Philippe Lagacé-Wiens MD n Cite as: CMAJ 2020 December 7;192:E1723-6. doi: 10.1503/cmaj.201170 CMAJ Podcasts: author interview at www.cmaj.ca/lookup/doi/10.1503/cmaj.201170/tab-related-content 48-year-old man presented to the emergency depart- ment with a 2-day history of pleuritic chest pain and KEY POINTS shortness of breath. His medical history included HIV • Bartonella quintana, the causal agent of trench fever, is infection,A diagnosed 14 years earlier in the context of intraven- transmitted by body lice (Pediculus humanus var. corporis). ous drug use. Three months previously, he had an undetectable • Although B. quintana is notorious for causing disease in the First viral load and a CD4 count of 94 cells/mm3 (normal range: 500– World War, outbreaks of trench fever have recently occurred in 1400 cells/mm3) or 0.09 (normal range 0.50–1.40) × 109/L. The urban populations experiencing homelessness. patient adhered to his prescribed antiretroviral regimen (darunavir, • B. quintana causes culture-negative endocarditis and may be ritonavir and abacavir-lamivudine) and prophylaxis against oppor- fatal without antimicrobial and surgical treatment, despite mild tunistic infections (valacyclovir, trimethoprim-sulfamethoxazole symptomatology during chronic bacteremia. Consultation with infectious disease specialists is encouraged. and fluconazole). In addition, the patient had a congenital soli- Because B. quintana evades identification in routine blood tary kidney with normal baseline renal function, alcohol expos- • cultures, diagnosis of B.
    [Show full text]
  • The Approved List of Biological Agents Advisory Committee on Dangerous Pathogens Health and Safety Executive
    The Approved List of biological agents Advisory Committee on Dangerous Pathogens Health and Safety Executive © Crown copyright 2021 First published 2000 Second edition 2004 Third edition 2013 Fourth edition 2021 You may reuse this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence. To view the licence visit www.nationalarchives.gov.uk/doc/ open-government-licence/, write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email [email protected]. Some images and illustrations may not be owned by the Crown so cannot be reproduced without permission of the copyright owner. Enquiries should be sent to [email protected]. The Control of Substances Hazardous to Health Regulations 2002 refer to an ‘approved classification of a biological agent’, which means the classification of that agent approved by the Health and Safety Executive (HSE). This list is approved by HSE for that purpose. This edition of the Approved List has effect from 12 July 2021. On that date the previous edition of the list approved by the Health and Safety Executive on the 1 July 2013 will cease to have effect. This list will be reviewed periodically, the next review is due in February 2022. The Advisory Committee on Dangerous Pathogens (ACDP) prepares the Approved List included in this publication. ACDP advises HSE, and Ministers for the Department of Health and Social Care and the Department for the Environment, Food & Rural Affairs and their counterparts under devolution in Scotland, Wales & Northern Ireland, as required, on all aspects of hazards and risks to workers and others from exposure to pathogens.
    [Show full text]
  • Bartonella: Feline Diseases and Emerging Zoonosis
    BARTONELLA: FELINE DISEASES AND EMERGING ZOONOSIS WILLIAM D. HARDY, JR., V.M.D. Director National Veterinary Laboratory, Inc. P.O Box 239 Franklin Lakes, New Jersey 07417 201-891-2992 www.natvetlab.com or .net Gingivitis Proliferative Gingivitis Conjunctivitis/Blepharitis Uveitis & Conjunctivitis URI Oral Ulcers Stomatitis Lymphadenopathy TABLE OF CONTENTS Page SUMMARY……………………………………………………………………………………... i INTRODUCTION……………………………………………………………………………… 1 MICROBIOLOGY……………………………………………………………………………... 1 METHODS OF DETECTION OF BARTONELLA INFECTION.………………………….. 1 Isolation from Blood…………………………………………………………………….. 2 Serologic Tests…………………………………………………………………………… 2 SEROLOGY……………………………………………………………………………………… 3 CATS: PREVALENCE OF BARTONELLA INFECTIONS…………………………………… 4 Geographic Risk factors for Infection……………………………………………………. 5 Risk Factors for Infection………………………………………………………………… 5 FELINE BARTONELLA DISEASES………………………………………………………….… 6 Bartonella Pathogenesis………………………………………………………………… 7 Therapy of Feline Bartonella Diseases…………………………………………………… 14 Clinical Therapy Results…………………………………………………………………. 15 DOGS: PREVALENCE OF BARTONELLA INFECTIONS…………………………………. 17 CANINE BARTONELLA DISEASES…………………………………………………………... 17 HUMAN BARTONELLA DISEASES…………………………………………………………… 18 Zoonotic Case Study……………………………………………………………………... 21 FELINE BLOOD DONORS……………………………………………………………………. 21 REFERENCES………………………………………………………………………………….. 22 This work was initiated while Dr. Hardy was: Professor of Medicine, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York and Director,
    [Show full text]
  • Bartonella Species Isolated from Rodents, Greece
    LETTERS Bartonella Species Germany). Polymerase chain reaction (AY435104–AY435113, isolated from (PCR) was performed by using two A. flavicollis) and representing four Isolated from oligonucleotides specific for the cit- novel genotypes, was 98% similar to Rodents, Greece rate synthase (gltA) gene of B. hense- B. taylorii (AF191502, isolated from lae Houston 1, primers BhCS 781.p A. sylvaticus) gltA gene. The second To the Editor: Domestic cats and and BhCS 1137.n. Negative and posi- group, consisting of seven isolates that human body lice have been identified tive controls (double-distilled H2O shared the same genotype (AY435114- as the vectors of Bartonella henselae and DNA from cultures of B. hense- AY435120 isolated from A. flavicol- and B. quintana, respectively, the pri- lae) were used in each PCR run. lis), was 99% similar to B. birtlesii mary sources of Bartonella-associat- Products of the correct size were puri- (AF204272 isolated from Apodemus ed human diseases (1). Bartonella fied (QIAquick PCR Purification kit, spp.). The third group consisted of two species are zoonotic agents that have Qiagen GmbH) and sequenced with isolates that shared the same genotype been isolated from a wide range of the same primers, BhCS 781.p and (AY435121 isolated from D. nitedula, mammals in the United States (2) and BhCS1137.n., in both directions, with and AY435122 isolated from A. flavi- Europe (3) and have been associated the Cy5/Cy5.5 Dye Primer Cycle collis); this group was 97% similar to with human diseases (4–5). Sequencing kit on a Long-Read B. grahamii strain V2 (Z70016 isolat- This study investigated the poten- Tower sequencer (Visible Genetics ed from Neomys fodiens).
    [Show full text]
  • INFECTIOUS DISEASES of HAITI Free
    INFECTIOUS DISEASES OF HAITI Free. Promotional use only - not for resale. Infectious Diseases of Haiti - 2010 edition Infectious Diseases of Haiti - 2010 edition Copyright © 2010 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN-13: 978-1-61755-090-4 ISBN-10: 1-61755-090-6 Visit http://www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER: Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. © 2010 GIDEON Informatics, Inc. www.gideononline.com All Rights Reserved. Page 2 of 314 Free. Promotional use only - not for resale. Infectious Diseases of Haiti - 2010 edition Introduction: The GIDEON e-book series Infectious Diseases of Haiti is one in a series of GIDEON ebooks which summarize the status of individual infectious diseases, in every country of the world.
    [Show full text]
  • 555 BCBSA Reference Number: 2.04.10 NCD/LCD: N/A
    Medical Policy Identification of Microorganisms Using Nucleic Acid Probes Table of Contents • Policy: Commercial • Coding Information • Information Pertaining to All Policies • Policy: Medicare • Description • References • Authorization Information • Policy History • Endnotes Policy Number: 555 BCBSA Reference Number: 2.04.10 NCD/LCD: N/A Related Policies • Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease, #171 • Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis, #711 Policy Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Medicare HMO BlueSM and Medicare PPO BlueSM Members The use of nucleic acid testing using a direct or amplified probe technique (without quantification of viral load) may be considered MEDICALLY NECESSARY for the following microorganisms: • Bartonella henselae or quintana • Bordetella pertussis • Candida species • Chlamydia pneumoniae • Chlamydiatrachomatis • Clostridium difficile • Enterococcus, vancomycin-resistant (eg, enterococcus vanA, vanB) • Enterovirus • Herpes simplex virus • Human papillomavirus • Influenza virus • Legionella pneumophila • Mumps • Mycobacterium species • Mycobacterium tuberculosis • Mycobacterium avium intracellulare • Mycoplasma pneumoniae • Neisseria gonorrhoeae 1 • Rubeola (measles) • Staphylococcus aureus • Staphylococcus aureus, methicillin resistant • Streptococcus, group A • Streptococcus, group B • Trichomonas vaginalis • Zika virus. The use of molecular diagnostics for the diagnosis and management
    [Show full text]
  • Human Bartonellosis: an Underappreciated Public Health Problem?
    Tropical Medicine and Infectious Disease Review Human Bartonellosis: An Underappreciated Public Health Problem? Mercedes A. Cheslock and Monica E. Embers * Division of Immunology, Tulane National Primate Research Center, Tulane University Health Sciences, Covington, LA 70433, USA; [email protected] * Correspondence: [email protected]; Tel.: +(985)-871-6607 Received: 24 March 2019; Accepted: 16 April 2019; Published: 19 April 2019 Abstract: Bartonella spp. bacteria can be found around the globe and are the causative agents of multiple human diseases. The most well-known infection is called cat-scratch disease, which causes mild lymphadenopathy and fever. As our knowledge of these bacteria grows, new presentations of the disease have been recognized, with serious manifestations. Not only has more severe disease been associated with these bacteria but also Bartonella species have been discovered in a wide range of mammals, and the pathogens’ DNA can be found in multiple vectors. This review will focus on some common mammalian reservoirs as well as the suspected vectors in relation to the disease transmission and prevalence. Understanding the complex interactions between these bacteria, their vectors, and their reservoirs, as well as the breadth of infection by Bartonella around the world will help to assess the impact of Bartonellosis on public health. Keywords: Bartonella; vector; bartonellosis; ticks; fleas; domestic animals; human 1. Introduction Several Bartonella spp. have been linked to emerging and reemerging human diseases (Table1)[ 1–5]. These fastidious, gram-negative bacteria cause the clinically complex disease known as Bartonellosis. Historically, the most common causative agents for human disease have been Bartonella bacilliformis, Bartonella quintana, and Bartonella henselae.
    [Show full text]
  • Seroprevalence of Six Pathogens Transmitted by the Ixodes Ricinus
    www.nature.com/scientificreports OPEN Seroprevalence of six pathogens transmitted by the Ixodes ricinus ticks in asymptomatic individuals Received: 9 October 2018 Accepted: 7 January 2019 with HIV infection and in blood Published: xx xx xxxx donors Agnieszka Pawełczyk1,5, Małgorzata Bednarska2,5, Justyna D. Kowalska3, Beata Uszyńska- Kałuża4, Marek Radkowski1 & Renata Welc-Falęciak 2,5 The objective of our study was to estimate the seroprevalence of six pathogens transmitted by ticks in HIV-infected persons and blood donors in Poland (B. burgdorferi s.l., A. phagocytophilum, Ehrlichia spp., Babesia spp., Rickettsia spp. Bartonella henselae) to assess the frequency of exposure to such microorganisms in immunocompetent and immunocompromised individuals in endemic regions for I. ricinus ticks. Serum samples were collected from 227 HIV-infected patients and 199 blood donors. All samples were analyzed for antibodies against six tick-borne pathogens and seroprevalence rates were statistically compared between two tested group as well as age, sex and lymphocyte T CD4+ level in HIV infected patients. The seroprevalence of tick-borne infections in HIV-infected patients is higher than that of the healthy population in Poland, although no association between serological status of patients and lymphocyte CD4+ T cell level has been observed. The frequency of tick-borne coinfections and doubtful results of serological tests were signifcantly higher in HIV-positive individuals. In Poland, the possibility of tick-borne diseases transmission with blood is rather negligible. Recently the experts of the Center for Disease Control and Prevention’s have summarized the alarming increase in the number of vector-borne disease cases reported in the United States and territories from 2004 to 20161.
    [Show full text]
  • Ru 2015 150 263 a (51) Мпк A61k 31/155 (2006.01)
    РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) (11) (13) RU 2015 150 263 A (51) МПК A61K 31/155 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ЗАЯВКА НА ИЗОБРЕТЕНИЕ (21)(22) Заявка: 2015150263, 01.05.2014 (71) Заявитель(и): НЕОКУЛИ ПТИ ЛТД (AU) Приоритет(ы): (30) Конвенционный приоритет: (72) Автор(ы): 01.05.2013 AU 2013901517 ПЕЙДЖ Стефен (AU), ГАРГ Санджай (AU) (43) Дата публикации заявки: 06.06.2017 Бюл. № 16 RU (85) Дата начала рассмотрения заявки PCT на национальной фазе: 01.12.2015 (86) Заявка PCT: AU 2014/000480 (01.05.2014) 2015150263 (87) Публикация заявки PCT: WO 2014/176634 (06.11.2014) Адрес для переписки: 190000, Санкт-Петербург, Box-1125, "ПАТЕНТИКА" A (54) СПОСОБЫ ЛЕЧЕНИЯ БАКТЕРИАЛЬНЫХ ИНФЕКЦИЙ (57) Формула изобретения 1. Способ лечения или профилактики бактериальной колонизации или инфекции у субъекта, включающий стадию: введения субъекту терапевтически эффективного количества робенидина или его терапевтически приемлемой соли, причем указанная A бактериальная колонизация или инфекция вызвана бактериальным агентом. 2. Способ по п. 1, отличающийся тем, что субъект выбран из группы, включающей: человека, животных, принадлежащих видам семейства псовых, кошачьих, крупного рогатого скота, овец, коз, свиней, птиц, рыб и лошадей. 3. Способ по п. 1, отличающийся тем, что робенидин вводят субъекту в дозе в диапазоне от 0,1 до 250 мг/кг массы тела. 4. Способ по любому из пп. 1-3, отличающийся тем, что бактериальный агент является 2015150263 грамположительным. 5. Способ по п. 4, отличающийся тем, что бактериальный агент выбран из
    [Show full text]